Multiple Sclerosis/ Demyelinating Disease

Contributing journals to this collection:
JAMA & Archives Journals

Citations 251-260 of 370 total displayed.

Past content

Original Contributions
Levetiracetam for Phasic Spasticity in Multiple Sclerosis

Kathleen Hawker; Elliot Frohman; Michael Racke
Arch Neurol 2003; 60: 1772-1774. [Abstract] [Full text] [PDF]  

Health Agencies Update
No Flu Vaccine–MS Link

Tracy Hampton
JAMA 2003; 290: 2655-b. [Extract] [Full text] [PDF]  

Original Contributions
Remyelinated Lesions in Multiple Sclerosis: Magnetic Resonance Image Appearance

Frederik Barkhof; Wolfgang Brück; Corline J. A. De Groot; Elisabeth Bergers; Sandra Hulshof; Jeroen Geurts; Chris H. Polman; Paul van der Valk
Arch Neurol 2003; 60: 1073-1081. [Abstract] [Full text] [PDF]  

Original Contributions
Excitatory Amino Acids and Multiple Sclerosis: Evidence From Cerebrospinal Fluid

Paola Sarchielli; Laura Greco; Ardesio Floridi; Alessandro Floridi; Virgilio Gallai
Arch Neurol 2003; 60: 1082-1088. [Abstract] [Full text] [PDF]  

Original Contributions
Pain in Patients With Multiple Sclerosis: A Population-Based Study

Kristina Bacher Svendsen; Troels Staehelin Jensen; Kim Overvad; Hans Jacob Hansen; Nils Koch-Henriksen; Flemming W. Bach
Arch Neurol 2003; 60: 1089-1094. [Abstract] [Full text] [PDF]  

From the Archives Journals
Risk of Multiple Sclerosis After Optic Neuritis

Leonard A. Levin; Simmons Lessell
JAMA 2003; 290: 403-404. [Extract] [Full text] [PDF]  

Letters
Epstein-Barr Virus and Risk of Multiple Sclerosis

Richard B. Tenser
JAMA 2003; 290: 192-b-193-b. [Extract] [Full text] [PDF]  

Letters
Epstein-Barr Virus and Risk of Multiple Sclerosis

Oliver Lily
JAMA 2003; 290: 192-a. [Extract] [Full text] [PDF]  

Letters
Epstein-Barr Virus and Risk of Multiple Sclerosis—Reply

Lynn Levin; Kassandra Munger; Alberto Ascherio
JAMA 2003; 290: 193. [Extract] [Full text] [PDF]  

Clinical Sciences
High- and Low-Risk Profiles for the Development of Multiple Sclerosis Within 10 Years After Optic Neuritis: Experience of the Optic Neuritis Treatment Trial

Optic Neuritis Study Group*
Arch Ophthalmol 2003; 121: 944-949. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37